Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 31, 2022
Patent Application Number
16629980
Date Filed
July 12, 2018
Patent Citations
Patent Primary Examiner
Patent abstract
The present invention provides compounds of Formula (I): (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
